China's Jinyu Bio-Technology lifts nine-month profit 40% to RMB226 million as ASF subunit vaccine enters registration review

The veterinary vaccine maker grew sales by almost 20% despite a shrinking national hog herd, helped by new FMD vaccines and expanding pet and service businesses.

Related Articles

Brazil's fat cattle prices set successive nominal records as China and US demand returns

29 Oct 2026

Nestlé Purina Petcare grows 5.3% in Q3 with double-digit growth in Asia, Oceania and Africa

23 Oct 2026

China's Sunner Development posts highest quarterly recurring profit since 2021 despite weak broiler prices

20 Oct 2026